Replimune (REPL) to Present New Biomarker & Pre-clinical Data for Lead Oncolytic Immunotherapy Programs

Go back to Replimune (REPL) to Present New Biomarker & Pre-clinical Data for Lead Oncolytic Immunotherapy Programs
Rider Explorations, Inc. (NASDAQ: REPL) Delayed: 34.00 +0.91 (2.75%)
Previous Close $33.09    52 Week High $1.45 
Open $33.32    52 Week Low $0.50 
Day High $34.03    P/E N/A 
Day Low $32.62    EPS $0.00 
Volume 401,297